With the upcoming introduction of the new EU HTA guidance in January 2025, sponsors in the pharmaceutical, Biotech and medical device sectors will face a significant regulatory shift. This change will demand the generation of a substantial body of evidence within stringent timelines. To help you prepare for this transition, we are hosting an informative webinar that will introduce the key aspects of EU HTA and its potential implications for your organization.
Speakers:
• Stephen Corson PhD, Associate Director, Statistics & Technical Solutions
• Eileen Holmes PhD, Associate Director, Statistics
• Lauren Rojas, Principal Statistician
• Melanie McGuigan, FSP Manager/ Programming Manager
Webinar Highlights:
• Introduction to EU HTA
• Key Differences from EMA
• Understanding PICOs
• Challenges and Opportunities
This webinar is an essential resource for regulatory professionals, clinical researchers, and anyone involved in HTAs.
Ensure your organization is well-prepared to meet the demands of the new EU HTA guidance and to position your products for success. Access the webinar recording and slides by completing the form below!
